JP2023507884A5 - - Google Patents
Info
- Publication number
- JP2023507884A5 JP2023507884A5 JP2022526044A JP2022526044A JP2023507884A5 JP 2023507884 A5 JP2023507884 A5 JP 2023507884A5 JP 2022526044 A JP2022526044 A JP 2022526044A JP 2022526044 A JP2022526044 A JP 2022526044A JP 2023507884 A5 JP2023507884 A5 JP 2023507884A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911038880.0A CN112746331A (zh) | 2019-10-29 | 2019-10-29 | 半衰期延长的药物及其文库、以及制备方法和应用 |
| CN201911038880.0 | 2019-10-29 | ||
| PCT/CN2020/123685 WO2021083077A1 (zh) | 2019-10-29 | 2020-10-26 | 半衰期延长的药物及其文库、以及制备方法和应用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023507884A JP2023507884A (ja) | 2023-02-28 |
| JP2023507884A5 true JP2023507884A5 (https=) | 2024-01-30 |
| JPWO2021083077A5 JPWO2021083077A5 (https=) | 2024-01-30 |
| JP7588427B2 JP7588427B2 (ja) | 2024-11-22 |
Family
ID=75640992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526044A Active JP7588427B2 (ja) | 2019-10-29 | 2020-10-26 | 半減期が延長した薬物およびそのライブラリー、ならびに製造方法と使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230024592A1 (https=) |
| EP (1) | EP4053311A4 (https=) |
| JP (1) | JP7588427B2 (https=) |
| KR (1) | KR102897184B1 (https=) |
| CN (2) | CN112746331A (https=) |
| AU (1) | AU2020374826B2 (https=) |
| CA (1) | CA3166865A1 (https=) |
| WO (1) | WO2021083077A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114539422B (zh) * | 2020-11-25 | 2024-03-29 | 安升（上海）医药科技有限公司 | 核酸多聚化介导的多价蛋白药物和疫苗的构建方法及应用 |
| CN115177740A (zh) * | 2021-04-01 | 2022-10-14 | 安升（上海）医药科技有限公司 | 核酸自组装介导的adc药物的构建方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006122787A1 (en) * | 2005-05-18 | 2006-11-23 | Ablynx Nv | Serum albumin binding proteins |
| AU2007338298B2 (en) * | 2006-12-22 | 2013-02-07 | Csl Behring Gmbh | Modified coagulation factors with prolonged in vivo half-life |
| CA2817448C (en) * | 2010-12-23 | 2019-01-22 | F. Hoffmann-La Roche Ag | Binding agent |
| JP5766296B2 (ja) * | 2010-12-23 | 2015-08-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用 |
| CN102827277B (zh) * | 2012-04-26 | 2014-12-10 | 拜明(苏州)生物技术有限公司 | 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 |
| CA2871386A1 (en) * | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
| CN108866635B (zh) * | 2017-05-09 | 2021-11-26 | 安升（上海）医药科技有限公司 | 多特异性蛋白药物及其文库、以及制备方法和应用 |
-
2019
- 2019-10-29 CN CN201911038880.0A patent/CN112746331A/zh active Pending
-
2020
- 2020-10-26 KR KR1020227018321A patent/KR102897184B1/ko active Active
- 2020-10-26 CA CA3166865A patent/CA3166865A1/en active Pending
- 2020-10-26 JP JP2022526044A patent/JP7588427B2/ja active Active
- 2020-10-26 EP EP20883596.7A patent/EP4053311A4/en active Pending
- 2020-10-26 CN CN202080076758.7A patent/CN114630928A/zh active Pending
- 2020-10-26 WO PCT/CN2020/123685 patent/WO2021083077A1/zh not_active Ceased
- 2020-10-26 AU AU2020374826A patent/AU2020374826B2/en active Active
- 2020-10-26 US US17/773,223 patent/US20230024592A1/en active Pending